Macular Hole

Pathophysiology & Epidemiology

Idiopathic macular holes form from anteroposterior and tangential traction that the vitreous cortex exerts on the fovea during an incomplete posterior vitreous detachment. The vitreous separates from the retina almost everywhere except directly over the fovea, where it stays abnormally adherent. That single point of residual attachment concentrates enough pulling force to tear the foveal tissue apart. The fovea is the thinnest point in the retina, so it is also the point least able to withstand this kind of traction.

Most cases occur in postmenopausal women in their sixties and seventies, likely reflecting age-related vitreous liquefaction and possibly hormonal factors as well. High axial myopia with a posterior staphyloma is a separate, independent risk factor: the staphyloma stretches the sclera and retina at the posterior pole, and that mechanical stress predisposes to both idiopathic-pattern and myopic macular holes.

Vitreomacular traction (VMT) syndrome is a related but distinct entity. The vitreous cortex stays attached to the fovea and produces a measurable distortion of the retinal contour, but the retina itself remains intact, with no full-thickness defect. When that same vitreofoveal attachment causes no morphologic change at all, it is called vitreomacular adhesion instead. OCT further classifies the adhesion by its width: focal at 1500 micrometers or less, diffuse above that. A focal, small adhesion without an epiretinal membrane is the setting where pharmacologic vitreolysis with ocriplasmin has the best chance of releasing the traction without surgery.

Clinical Presentation & Testing

Patients typically present with central metamorphopsia and a gradual decline in visual acuity, reflecting direct disruption of the foveal photoreceptor architecture. The Watzke-Allen test is the classic bedside maneuver: a thin slit-lamp beam is swept across the fovea, and the patient reports whether it looks broken, narrowed, or distorted. A perceived break supports a full-thickness hole, but OCT has largely replaced the test for definitive diagnosis.

Gass Staging

The Gass classification grades macular holes by their stage of vitreofoveal separation:

• Stage 1: an impending (threatened) hole, with loss of the normal foveal depression and a yellow spot or ring from foveolar detachment, but no full-thickness defect yet.
• Stage 2: a small, full-thickness hole begins to form.
• Stage 3: a larger full-thickness hole, with the vitreous still attached to the macula.
• Stage 4: a full-thickness hole with a complete posterior vitreous detachment, confirmed clinically by a Weiss ring. That ring is the key feature separating stage 4 from stage 3, where vitreomacular attachment still persists.

OCT Imaging

Optical coherence tomography is the gold-standard imaging modality for diagnosing and staging macular holes. Its cross-sectional resolution measures hole diameter precisely and confirms full-thickness involvement, a level of precision clinical exam alone cannot match.

Surgical Treatment

The standard treatment for a full-thickness macular hole is pars plana vitrectomy with removal of the posterior hyaloid and peeling of the internal limiting membrane (ILM), followed by gas tamponade. Peeling the ILM releases any residual tangential traction at the hole's edges, and this closes the hole in the great majority of patients.

Gas tamponade choice determines how long support lasts. Perfluoropropane (C3F8) persists for roughly six to eight weeks, longer than sulfur hexafluoride (SF6, about two weeks) or filtered air (a few days). After surgery, patients are usually instructed to hold a face-down (prone) position so the bubble stays against the macula. That positioning is the entire point of the maneuver: it maximizes the surface tension holding the hole's edges together while they heal.

A nonsurgical option exists for select cases. Ocriplasmin, a recombinant protease given as an intravitreal injection, cleaves fibronectin and laminin at the vitreoretinal interface and releases vitreomacular traction pharmacologically. It works best for small holes with a focal area of adhesion, not broad traction across the macula.

Surgical Prognosis

The strongest predictor of anatomic closure after surgery is the hole's minimum linear diameter on OCT. Smaller holes close at meaningfully higher rates than larger ones. That is the clinical argument for early referral and surgery, before a hole has the chance to enlarge further.

Macular Pseudohole

A macular pseudohole is not a true retinal defect. It results from centripetal traction by an epiretinal membrane, which pulls tissue inward and creates a steep foveal contour that mimics a hole on clinical exam. OCT settles the question: a true full-thickness hole shows an actual gap in the retinal tissue, while a pseudohole has a continuous, intact photoreceptor layer underneath. What looks like a hole is really just a contour illusion over otherwise intact retina.

High-Yield Pearls

• Positive Watzke-Allen = a perceived break in a light beam swept across the fovea, supporting a full-thickness hole.
• Face-down positioning after gas tamponade keeps the bubble against the macula; that's the entire point of the maneuver.
• A pseudohole looks like a hole clinically but has an intact photoreceptor layer on OCT. Always confirm with imaging before counseling a patient on surgery.

Related Topics

Continue exploring Retina & Vitreous: